- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 7, 2026 | 23.78M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 23.84M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 24.79M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $573K |
| Stock Repurchased | Q1 2026 · Dec 31, 2025 | $7.6M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $675K |
| Capex | Q1 2026 · Mar 31, 2026 | $1.53M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.26M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $6.95M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $4.91M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $14.11M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.48M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $538.99M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $528.61M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $503.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $493.96M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $48.53M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $46.86M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $52.48M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $51.72M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $174.29M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $164.66M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $591.47M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $580.34M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.46 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.41 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.46 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.43 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $5.84M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $6.37M |
| Net Income | Q1 2026 · Mar 31, 2026 | $10.93M |
| Net Income | Q1 2026 · Mar 31, 2025 | $10.28M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $12.39M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $11.59M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $14.94M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $17.19M |
| Revenue | Q1 2026 · Mar 31, 2026 | $21.55M |
| Revenue | Q1 2026 · Mar 31, 2025 | $24.29M |